Vitality Biopharma Inc. (VBIO)
Stock Price:
$0.1200 USD
0.0000 (0.00%)
Updated November 25, 12:42 PM EST - Market open
Key Info
| Market Cap |
6.10M |
| Revenue (ttm) |
258,288 |
| Net Income (ttm) |
-2.76M |
| Shares Out |
50.84M |
| EPS (ttm) |
-0.05 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
November 25 |
| Last Price |
$0.1200 |
| Previous Close |
$0.1200 |
| Change ($) |
0.0000 |
| Change (%) |
0.00% |
| Day's Open |
0.1200 |
| Day's Range |
0.1200 - 0.1200 |
| Day's Volume |
31,264 |
| 52-Week Range |
0.01 - 0.35 |
More Stats
| Market Cap |
6.10M |
| Enterprise Value |
5.16M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
50.84M |
| Float |
34.10M |
| EPS (basic) |
-0.04 |
| EPS (diluted) |
-0.05 |
| FCF / Share |
-0.05 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
3.87 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
23.62 |
| PB Ratio |
9.53 |
| Revenue |
258,288 |
| Operating Income |
-2.70M |
| Net Income |
-2.76M |
| Free Cash Flow |
-2.70M |
| Net Cash |
938,708 |
| Net Cash / Share |
0.02 |
| Gross Margin |
-76.07% |
| Operating Margin |
-1,043.97% |
| Profit Margin |
n/a |
| FCF Margin |
-1,045.74% |
| ROA |
-59.59% |
| ROE |
-188.36% |
| ROIC |
411.80% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
10.4
Current: $0.1200
High
10.4
Target: 10.40
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|
| Revenue | - | - | 0.10 | 0.16 | 0.25 | 0.25 | - | - | - |
| Revenue Growth | - | - | -37.31% | -34.22% | 1.09% | - | - | - | - |
| Gross Profit | - | - | 0.02 | 0.06 | 0.10 | 0.12 | - | - | - |
| Operating Income | -3.69 | -4.57 | -4.40 | -3.47 | -2.74 | -3.81 | -3.60 | -2.55 | -1.30 |
| Net Income | -4.37 | -13.12 | -4.31 | -5.22 | -0.14 | -4.05 | -4.15 | -2.74 | -1.32 |
| Shares Outstanding | 51.54 | 33.00 | 23.12 | 13.59 | 7.54 | 7.04 | 6.01 | 5.34 | 5.15 |
| Earnings Per Share | -0.08 | -0.61 | -0.19 | -0.38 | -0.02 | -0.60 | -0.70 | -0.50 | -0.30 |
| Operating Cash Flow | -3.59 | -3.67 | -2.89 | -1.38 | -1.69 | -2.50 | -2.13 | -1.65 | -0.24 |
| Free Cash Flow | -3.59 | -3.67 | -2.89 | -1.38 | -1.69 | -2.50 | -2.13 | -1.65 | -0.24 |
| Cash & Equivalents | 2.43 | 6.01 | 0.66 | 1.15 | 0.10 | 0.39 | 1.40 | 0.39 | 0.53 |
| Total Debt | 0.42 | 0.30 | - | - | - | - | - | 0.58 | 0.47 |
| Net Cash / Debt | 2.01 | 5.71 | 0.66 | 1.15 | 0.10 | 0.39 | 1.40 | -0.19 | 0.06 |
| Assets | 2.57 | 6.08 | 0.68 | 1.18 | 0.13 | 0.46 | 1.42 | 0.54 | 0.53 |
| Liabilities | 1.28 | 1.05 | 0.35 | 0.80 | 0.65 | 1.54 | 1.53 | 1.11 | 0.58 |
| Book Value | 1.28 | 5.02 | 0.32 | 0.37 | -0.52 | -1.08 | -0.11 | -0.57 | -0.05 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Vitality Biopharma Inc. |
| Country |
United States |
| Employees |
3 |
| CEO |
Michael Cavanaugh |
Stock Information
| Ticker Symbol |
VBIO |
| Stock Exchange |
US OTC |
| Sector |
Healthcare |
| Industry |
Biotechnology |
| Unique Identifier |
OTCMKTS: VBIO |
Description
Vitality Biopharma engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was founded in 2007 and is headquartered in Los Angeles, California.